Carlson College of Veterinary Medicine

R. B. Cope, Stang, B. V., Valentine, B. A., and Bermudez, L. E., “Topical exposure to exogenous ultraviolet-irradiated urocanic acid enhances Mycobacterium ulcerans infection in a Crl:IAF(HA)-hrBR hairless guinea-pig model of Buruli ulcer disease.”, Photodermatology, photoimmunology & photomedicine, vol. 20, no. 1, pp. 14-20, 2004.

G. Carter, Wu, M., Drummond, D. C., and Bermudez, L. E., “Characterization of biofilm formation by clinical isolates of Mycobacterium avium.”, Journal of medical microbiology, vol. 52, no. Pt 9, pp. 747-52, 2003.

L. E. Bermudez, Kolonoski, P., Petrofsky, M., Wu, M., Inderlied, C. B., and Young, L. S., “Mefloquine, moxifloxacin, and ethambutol are a triple-drug alternative to macrolide-containing regimens for treatment of Mycobacterium avium disease.”, The Journal of infectious diseases, vol. 187, no. 12, pp. 1977-80, 2003.

J. P. Bannantine, Huntley, J. F. J., Miltner, E., Stabel, J. R., and Bermudez, L. E., “The Mycobacterium avium subsp. paratuberculosis 35 kDa protein plays a role in invasion of bovine epithelial cells.”, Microbiology (Reading, England), vol. 149, no. Pt 8, pp. 2061-9, 2003.

L. Danelishvili, McGarvey, J., Li, Y. -jun, and Bermudez, L. E., “Mycobacterium tuberculosis infection causes different levels of apoptosis and necrosis in human macrophages and alveolar epithelial cells.”, Cellular microbiology, vol. 5, no. 9, pp. 649-60, 2003.

L. Danelishvili, McGarvey, J., Li, Y. -jun, and Bermudez, L. E., “Mycobacterium tuberculosis infection causes different levels of apoptosis and necrosis in human macrophages and alveolar epithelial cells.”, Cell Microbiol, vol. 5, no. 9, pp. 649-60, 2003.

L. Danelishvili and Bermudez, L. E., “Role of type I cytokines in host defense against Mycobacterium avium infection.”, Current pharmaceutical design, vol. 9, no. 1, pp. 61-5, 2003.

L. Danelishvili and Bermudez, L. E., “Role of type I cytokines in host defense against Mycobacterium avium infection.”, Curr Pharm Des, vol. 9, no. 1, pp. 61-5, 2003.

L. E. Bermudez, Reynolds, R., Kolonoski, P., Aralar, P., Inderlied, C. B., and Young, L. S., “Thiosemicarbazole (thiacetazone-like) compound with activity against Mycobacterium avium in mice.”, Antimicrobial agents and chemotherapy, vol. 47, no. 8, pp. 2685-7, 2003.

L. E. Bermudez, Sangari, F. J., Kolonoski, P., Petrofsky, M., and Goodman, J., “The efficiency of the translocation of Mycobacterium tuberculosis across a bilayer of epithelial and endothelial cells as a model of the alveolar wall is a consequence of transport within mononuclear phagocytes and invasion of alveolar epithelial cells.”, Infection and immunity, vol. 70, no. 1, pp. 140-6, 2002.

M. M. Samrakandi, Cirillo, S. L. G., Ridenour, D. A., Bermudez, L. E., and Cirillo, J. D., “Genetic and phenotypic differences between Legionella pneumophila strains.”, Journal of clinical microbiology, vol. 40, no. 4, pp. 1352-62, 2002.

L. Broxmeyer, Sosnowska, D., Miltner, E., Chacon, O., Wagner, D., McGarvey, J., Barletta, R. G., and Bermudez, L. E., “Killing of Mycobacterium avium and Mycobacterium tuberculosis by a mycobacteriophage delivered by a nonvirulent mycobacterium: a model for phage therapy of intracellular bacterial pathogens.”, The Journal of infectious diseases, vol. 186, no. 8, pp. 1155-60, 2002.

D. Wagner, Sangari, F. J., Kim, S., Petrofsky, M., and Bermudez, L. E., “Mycobacterium avium infection of macrophages results in progressive suppression of interleukin-12 production in vitro and in vivo.”, Journal of leukocyte biology, vol. 71, no. 1, pp. 80-8, 2002.

Y. -jun Li, Petrofsky, M., and Bermudez, L. E., “Mycobacterium tuberculosis uptake by recipient host macrophages is influenced by environmental conditions in the granuloma of the infectious individual and is associated with impaired production of interleukin-12 and tumor necrosis factor alpha.”, Infection and immunity, vol. 70, no. 11, pp. 6223-30, 2002.

J. McGarvey and Bermudez, L. E., “Pathogenesis of nontuberculous mycobacteria infections.”, Clinics in chest medicine, vol. 23, no. 3, pp. 569-83, 2002.

L. E. Bermudez, Inderlied, C. B., Kolonoski, P., Petrofsky, M., Aralar, P., Wu, M., and Young, L. S., “Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium.”, Antimicrobial agents and chemotherapy, vol. 45, no. 1, pp. 217-22, 2001.

L. E. Bermudez and Sangari, F. J., “Cellular and molecular mechanisms of internalization of mycobacteria by host cells.”, Microbes and infection / Institut Pasteur, vol. 3, no. 1, pp. 37-42, 2001.

A. Limia, Sangari, F. J., Wagner, D., and Bermudez, L. E., “Characterization and expression of secA in Mycobacterium avium.”, FEMS microbiology letters, vol. 197, no. 2, pp. 151-7, 2001.

P. M. Roger and Bermudez, L. E., “Infection of mice with Mycobacterium avium primes CD8+ lymphocytes for apoptosis upon exposure to macrophages.”, Clinical immunology (Orlando, Fla.), vol. 99, no. 3, pp. 378-86, 2001.

S. L. Cirillo, Bermudez, L. E., El-Etr, S. H., Duhamel, G. E., and Cirillo, J. D., “Legionella pneumophila entry gene rtxA is involved in virulence.”, Infection and immunity, vol. 69, no. 1, pp. 508-17, 2001.

F. J. Sangari, Goodman, J., Petrofsky, M., Kolonoski, P., and Bermudez, L. E., “Mycobacterium avium invades the intestinal mucosa primarily by interacting with enterocytes.”, Infection and immunity, vol. 69, no. 3, pp. 1515-20, 2001.

L. S. Young and Bermudez, L. E., “Perspective on animal models: chronic intracellular infections.”, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol. 33 Suppl 3, pp. S221-6, 2001.

J. A. McGarvey and Bermudez, L. E., “Phenotypic and genomic analyses of the Mycobacterium avium complex reveal differences in gastrointestinal invasion and genomic composition.”, Infection and immunity, vol. 69, no. 12, pp. 7242-9, 2001.

G. A. Cangelosi, Palermo, C. O., and Bermudez, L. E., “Phenotypic consequences of red-white colony type variation in Mycobacterium avium.”, Microbiology (Reading, England), vol. 147, no. Pt 3, pp. 527-33, 2001.

L. E. Bermudez, Inderlied, C. B., Kolonoski, P., Wu, M., Aralar, P., and Young, L. S., “Telithromycin is active against Mycobacterium avium in mice despite lacking significant activity in standard in vitro and macrophage assays and is associated with low frequency of resistance during treatment.”, Antimicrobial agents and chemotherapy, vol. 45, no. 8, pp. 2210-4, 2001.